Ralliant (NYSE:RAL) Stock Rating Upgraded by Wall Street Zen

Ralliant (NYSE:RAL) was upgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday.

Other equities analysts have also recently issued reports about the stock. Royal Bank Of Canada boosted their target price on shares of Ralliant from $71.00 to $73.00 and gave the company a “sector perform” rating in a research note on Friday, July 31st. Zacks Research raised shares of Ralliant from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. Truist Financial reaffirmed a “buy” rating and issued a $82.00 price objective (up from $68.00) on shares of Ralliant in a report on Friday, July 31st. Oppenheimer upped their price objective on shares of Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Finally, BMO Capital Markets initiated coverage on shares of Ralliant in a research note on Monday, July 20th. They set a “market perform” rating and a $78.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Ralliant presently has an average rating of “Moderate Buy” and an average price target of $75.70.

Ralliant Stock Up 0.2%

Shares of RAL stock opened at $63.72 on Friday. Ralliant has a twelve month low of $37.27 and a twelve month high of $75.41. The stock has a market cap of $7.05 billion, a P/E ratio of -5.87, a P/E/G ratio of 2.36 and a beta of 1.61. The stock has a 50 day moving average of $68.94 and a 200 day moving average of $55.94. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75.

Ralliant (NYSE:RAL) last released its quarterly earnings data on Thursday, July 30th. The company reported $0.68 EPS for the quarter, topping the consensus estimate of $0.63 by $0.05. The business had revenue of $567.80 million for the quarter. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, sell-side analysts expect that Ralliant will post 2.87 EPS for the current year.

Insider Activity

In other news, SVP Karen M. Bick sold 6,062 shares of Ralliant stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $72.00, for a total value of $436,464.00. Following the sale, the senior vice president owned 31,668 shares in the company, valued at $2,280,096. This trade represents a 16.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of the business’s stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $71.79, for a total transaction of $928,675.44. Following the sale, the chief executive officer directly owned 251,967 shares of the company’s stock, valued at $18,088,710.93. This represents a 4.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by company insiders.

Institutional Investors Weigh In On Ralliant

Institutional investors have recently bought and sold shares of the company. Danske Bank A S acquired a new position in shares of Ralliant during the fourth quarter valued at approximately $25,000. Dunhill Financial LLC acquired a new stake in shares of Ralliant in the second quarter worth approximately $25,000. Allworth Financial LP boosted its stake in shares of Ralliant by 134.4% in the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after acquiring an additional 293 shares during the last quarter. Palisade Asset Management LLC purchased a new stake in shares of Ralliant during the third quarter worth approximately $26,000. Finally, BOKF NA purchased a new stake in shares of Ralliant during the third quarter worth approximately $29,000.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.